PubMed Health⌕ Search

Biomedical subjects

W Volkmuth

Publications and source records attributed to W Volkmuth.

3 recordsLinked to original sources

Evidence for sequence-independent evolutionary traces in genomics data.

Sequence conservation during evolution is the foundation for the functional classification of the enormous number of new protein sequences being discovered in the current era of genome sequencing. Conventional methods to detect homologous proteins are not always able to distinguish between true homologs and false positive hits in the twilight zone of sequence similarity. Several different approaches have been proposed to improve the sensitivity of these methods. Among the most successful are sequence profiles, multi-linked alignment, and threading. However, evolution might offer up other clues about a protein's ancestry that are sequence independent. Here we report the discovery of two such traces of evolution that could potentially be used to help infer the fold of a protein and hence improve the ability to predict the biochemical function. The first such evolutionary trace is a conservation of fold along the genome, i.e. nearby genes tend to share a fold more often than expected by chance alone--a not unexpected observation, but one which holds true even when no pair of genes being examined share appreciable homology. The second such evolutionary trace is, surprisingly, present in expression data: genes that are correlated in expression are more apt to share a fold than two randomly chosen genes. This result is surprising because correlations in expression have previously only been considered useful for determining biological function (e.g. what pathway a particular gene fits into), yet the observed fold enrichment in the expression data permits us to say something about biochemical function since fold corresponds strongly with biochemical function. Again, the fold enrichment observed in the expression data is apparent even when no pair of genes being examined share appreciable homology.

Arabidopsis↗

Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes.

We wish to identify genes associated with disease. To do so, we look for novel genes whose expression patterns mimic those of known disease-associated genes, using a method we call Guilt-by-Association (GBA), on the basis of a combinatoric measure of association. Using GBA, we have examined the expression of 40,000 human genes in 522 cDNA libraries, and have discovered several hundred previously unidentified genes associated with cancer, inflammation, steroid-synthesis, insulin-synthesis, neurotransmitter processing, matrix remodeling, and other disease processes. The majority of the genes thus discovered show no sequence similarity to known genes, and thus could not have been identified by homology searches. We present here an example of the discovery of eight genes associated with prostate cancer. Of the 40,000 most-abundant human genes, these 8 are the most closely linked to the known diagnostic genes, and thus are prime targets for pharmaceutical research.

Gene Expression Profiling↗

Pharmaceutical target discovery using Guilt-by-Association: schizophrenia and Parkinson's disease genes.

We wish to identify genes associated with disease. To do so, we look for novel genes whose expression patterns mimic those of known disease-associated genes, a method we call Guilt-by-Association (GBA). GBA uses a combinatoric measure of association that provides superior results to those from correlation measures used in previous expression analyses. Using GBA, we have examined the expression of 40,000 human genes in 522 cDNA libraries, and have identified several hundred genes associated with known cancer, inflammation, steroid-synthesis, insulin-synthesis, neurotransmitter processing, matrix remodeling and other disease genes. The majority of the genes thus discovered show no significant sequence similarity to known genes, and thus could not have been identified by homology searches. We present here an example of the discovery of five genes associated with schizophrenia and Parkinson's disease. Of the 40,000 most-abundant human genes, these five genes are the most closely linked to the known disease genes, and thus are prime targets for pharmaceutical intervention.

Algorithms↗